Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancerLuisa Klemke, Ramona Schulz‐Heddergott|Cell Death and Disease|2021Cited by 109
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Ramona Schulz‐Heddergott|Cell Death and Differentiation|2025Cited by 9
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancerKim Lucia Schneider, Ramona Schulz‐Heddergott|Oncogenesis|2025Cited by 5
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibitionTamara Isermann, Ramona Schulz‐Heddergott|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1